HIF1A and delirium: This review explores the hypothesis that dexmedetomidine may prevent POD in elderly patients by modulating HIF-1α pathways to provide novel insights into potential therapeutic targets for the prevention and treatment of Dex-induced postoperative delirium in geriatric patients.